Sacheu Spot Eraser

Manufacturer
Sacheu Beauty Inc. | Product Society LLC
Effective date
2022-12-05
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:52:22

Label at a glance#

ProductSacheu Spot Eraser
Active ingredientBENZOYL PEROXIDE
Label structure9 sections

Indications and uses

For the treatment of acne

Dosage and administration

Clean the skin thoroughly before applying this product Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with on application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day. If going outside, appl...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Benzoyl Peroxide (2.5%)

Purpose

OTC - PURPOSE SECTION

Acne Medication

Uses

INDICATIONS & USAGE SECTION

  • For the treatment of acne

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

For external use only. Do not use if you have very sensitive skin or are sensitive to benzoyl peroxide.

OTC - WHEN USING SECTION

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Avoid unnecessary sun exposure and use a sunscreen. Avoid contact with the eyes, lips, and mouth. Avoid contact with hair and dyed fabrics, which may be bleached by this product. Skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.

OTC - STOP USE SECTION

Stop use and ask a doctor if irritation becomes severe.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Clean the skin thoroughly before applying this product
  • Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with on application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
  • If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water (Aqua), Kaolin, Bentonite, Propylene Glycol, Hydroxyethyl Behenamidopropyl Dimonium Chloride, Butyrospermum Parkii (Shea) Butter Extract, Magnesium Aluminum Silicate, Euphorbia Cerifera (Candelilla) Wax, Xanthan Gum, Allantoin, Bisabolol, Caprylyl Glycol, Sodium Citrate, Phenoxyethanol, Ethylhexylglycerin.

SPL UNCLASSIFIED SECTION

imported/distributed by
Gloss Brands Europe
with offices at
Keizersgracht 391a,
Amsterdam, 1016EJ,
Noord Holland, The
Netherlands.

imported/
distributed by Gloss
Brands LLC with offices
at 3381 Robertson
Place, Los Angeles, CA,
90034, USA.

PRINCIPAL DISPLAY PANEL - 15 ml Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

spot
eraser

blemish drying
lotion

0.5 fl oz / 15 ml

SACHEU

PRINCIPAL DISPLAY PANEL - 15 ml Tube Carton
PRINCIPAL DISPLAY PANEL - 15 ml Tube Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
200009benzoyl peroxide 2.5 % Topical LotionPSN1
200009benzoyl peroxide 25 MG/ML Topical LotionSCD1
200009benzoyl peroxide 2.5 % Topical LotionSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d9d61457-6a5a-41fc-b418-e5479a2904b7Product name220230303
32012d5c-25ac-49c7-9d4c-1313177fff7cProduct name120230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06eProduct name120220128
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
3f45980c-c196-47e5-0e5e-48b7c57327c5Product name520200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfaProduct name120170810

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
83101-004-012025-01-30C16284748780-12cef2736-b269-d83d-e063-dadaa90ab31fSacheu Spot Eraser

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83101-004-01Sacheu Spot Eraser15 mL in 1 TUBELOTION151

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83101-004SACHEU SPOT ERASER (BENZOYL PEROXIDE) LOTION [SACHEU BEAUTY INC.]1Legacy NDC, 1 package rows20221209_fb181405-a48e-443a-9924-e9eeb9906a38.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83101-00483101-004-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bdd0f399-1c92-4424-ac0a-e0c599a95297fb181405-a48e-443a-9924-e9eeb9906a382022-12-05WarningsExact identifier
spl id: bdd0f399-1c92-4424-ac0a-e0c599a95297
spl set id: fb181405-a48e-443a-9924-e9eeb9906a38

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.